SciRisk Calculate your ESCRC
As of 2026-06-30| Model v5.4.2| Priors 2026.09-5| Calculated 2026-09-21| 100,000 paths · 95% · 365d| BETA Methodology

SciRisk 100 · Healthcare Equipment · Rank 58 of 100

Thermo Fisher Scientific

TMO · USA · Healthcare Equipment   SC4 High

Economic Supply Chain Risk Capital
$43.7m
95% one-year Value-at-Risk · interval $43.7m to $43.9m (0.4% wide)
Risk Capital Intensity
0.102%
of $43.0bn revenue · rank #35 of 100
Global rank
#58
of 100 by ESCRC
Sector rank
#1
of 8 in Healthcare Equipment
Expected Shortfall
$60.1m
Mean loss beyond ESCRC
Expected annual loss
$11.3m
Ordinary year
Revenue / COGS
43.0 / 25.0
USD bn · gross margin 41%
Suppliers modelled
10
2 correlated geographies

What does this ESCRC number mean?

An ESCRC of $43.7m is the estimated economic supply-chain risk capital requirement generated by the SciRisk ESCRC model for Thermo Fisher Scientific under the stated assumptions: a 365-day horizon, 100,000 simulated years, and the 95% tail of the resulting loss distribution. Beyond that threshold the average loss — the Expected Shortfall — is $60.1m; in an ordinary year the expected loss is $11.3m.

Value-at-Risk: the portfolio loss not exceeded with the chosen confidence level. Read as the ESCRC risk capital — the loss the firm should be prepared to absorb in a bad year. Model-implied and intended for screening and ranking, not a calibrated capital figure.

Supply Chain Risk Capital Profile

Where the risk capital comes from. Every column is a production-engine output for this network — nothing is inferred.

By tier

Tier 1
94%
Tier 2
5%
Tier 3
1%

Share of summed standalone VaR. Deeper tiers are attenuated by the engine's echelon buffer factors and capped by flow conservation.

By supplier geography

Germany
60%
USA
33%
Switzerland
7%

Major-event risk is correlated within a geography group (rho = 0.35), so concentration here compounds.

By supplier industry

pharma bio
74%
chemicals materials
11%
electronics assembly
11%
packaging
4%
metals materials inputs
1%
equipment precision
0%

Buckets are the calibrated-priors industry classes that set each supplier's minor-event rate.

Largest supplier share
32%
Merck KGaA
Top-3 concentration
72%
of summed standalone VaR
Tier-1 share of risk
94%
Direct suppliers
Diversification benefit
45.7%
vs. sum of standalone VaR
SupplierTierCountry ExposureUSD m Standalone VaRUSD m Expected lossUSD m Tail intensityrevenue-days RoESCRCx
Merck KGaACell culture media/chemicals T1 Germany 1250 25.4 4.1 4.3 34.5
SartoriusSingle-use bioprocess bags T1 Germany 1000 20.4 3.2 4.3 34.5
RepligenChromatography resins T1 USA 750 11.9 1.6 3.4 44.4
JabilInstrument EMS T1 USA 1125 8.5 0.8 1.6 93.0
Corning Life SciencesLabware glass T1 USA 1000 6.2 0.5 1.3 113.0
AmcorMedical plastics T1 Switzerland 750 3.0 0.4 0.8 178.0
Evonik Industries AGChemical intermediates T2 Germany 625 2.3 0.2 1.3 113.0
SHL MedicalMolly modular autoinjector platform for drug-device combination product assembly T2 Switzerland 150 1.8 0.3 4.3 34.5
GlencorePrecious metal inputs T3 Switzerland 250 0.9 0.1 2.6 56.6
EntegrisFiltration components T2 USA 750 0.0 0.2

Scenario Analysis — coming in Phase 2

Recovery-time, supplier-diversification, inventory and geographic-diversification scenarios for Thermo Fisher Scientific are not part of this release. The ESCRC Calculator already supports what-if analysis on a network you build yourself.

Sector peers

Nearest-ranked companies in Healthcare Equipment. Thermo Fisher Scientific is highlighted.

Open in Compare
RankCompanyTickerCountrySectorRevenueUSD bnESCRCUSD mESCRC / Revenue%Risk GradeChange
58 Thermo Fisher Scientific TMO USA Healthcare Equipment 43.0 43.7 0.102 SC4 High 0.0%
73 Danaher DHR USA Healthcare Equipment 24.0 24.3 0.101 SC4 High 0.0%
80 Abbott Laboratories ABT USA Healthcare Equipment 42.0 18.6 0.044 SC1 Very Low ▲ +0.5%
89 Medtronic MDT Ireland Healthcare Equipment 32.0 14.1 0.044 SC1 Very Low ▲ +0.3%
91 Becton Dickinson BDX USA Healthcare Equipment 20.0 11.4 0.057 SC2 Low ▼ -1.5%
94 Koninklijke Philips PHG Netherlands Healthcare Equipment 20.0 8.9 0.045 SC1 Very Low ▲ +0.5%

See this for your own supply chain

You are looking at Thermo Fisher Scientific's supply-chain risk capital: $43.7m against $43.0bn of revenue, driven mostly by Merck KGaA and Germany. The calculator runs the same engine on a network you build yourself.

ESCRC calculated using SciRisk ESCRC Model v5.4.2 · calibrated priors 2026.09-5
Company data as of 2026-06-30 · ESCRC calculated 2026-09-21 · dataset 2026.09-23 Beta
Simulation
100,000 Monte Carlo paths · 95% confidence · 365-day horizon
Seed
20260821 · regional correlation ρ = 0.35
Input basis
Curated network, calibrated-prior parameters
Input fingerprint
3a5745d4a43a
Input provenance for Thermo Fisher Scientific
Financials
Curated from the company's most recent reported full financial year, as filed.
Network
Curated from company supplier disclosure; purchase volumes declared as a share of reported COGS.
Parameters
lambda1/lambda2 = calibrated ESCRC priors 2026.09-5 bucket defaults; r1/r2 = median of the shipped production preset networks within the same industry x geography cell when that cell has enough independent data, else the same industry-only bucket median, or (for industries with no preset supplier coverage) a directly-cited external recovery-event duration where one was found; ic = the same preset-network median (no external benchmark exists for this parameter for any industry). All three clamped into externally-cited recovery-time/BI-loss bounds per field.
Fallback
Some suppliers resolve to an industry bucket with no coverage in the shipped preset networks (metals materials inputs). Their recovery times use the median across all preset suppliers rather than a bucket-specific or externally-cited one.
Fallback
Some suppliers resolve to an industry bucket with no preset coverage for revenue-at-risk fraction (packaging, metals materials inputs). This parameter has no external benchmark for any industry in this dataset, so it uses the median across all preset suppliers.
SciRisk ESCRC is an analytical estimate generated using the SciRisk Economic Supply Chain Risk Capital methodology. It is not a credit rating, investment recommendation or statement of financial condition. Figures are model-implied and intended for screening and comparison, not as calibrated capital requirements.

Beta / preliminary dataset. Company inputs are analyst-curated from public annual reports and public supply-chain disclosure. ESCRC itself is computed by the production ESCRC engine — only the INPUTS on this page are preliminary.